Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection

An effective therapeutic vaccine for the treatment of chronic hepatitis C virus (HCV) infection, as an adjunct to newly developed directly-acting antivirals (DAA), or for the prevention of reinfection, would significantly reduce the global burden of disease associated with chronic HCV infection. A r...

Descripción completa

Detalles Bibliográficos
Autores principales: Swadling, Leo, Halliday, John, Kelly, Christabel, Brown, Anthony, Capone, Stefania, Ansari, M. Azim, Bonsall, David, Richardson, Rachel, Hartnell, Felicity, Collier, Jane, Ammendola, Virginia, Del Sorbo, Mariarosaria, Von Delft, Annette, Traboni, Cinzia, Hill, Adrian V. S., Colloca, Stefano, Nicosia, Alfredo, Cortese, Riccardo, Klenerman, Paul, Folgori, Antonella, Barnes, Eleanor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041021/
https://www.ncbi.nlm.nih.gov/pubmed/27490575
http://dx.doi.org/10.3390/vaccines4030027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041021/
https://www.ncbi.nlm.nih.gov/pubmed/27490575
http://dx.doi.org/10.3390/vaccines4030027

Ejemplares similares